The Biomedical Engineering Society (BMES) held their annual meeting October 11-14, 2017 in Phoenix, AZ. Nine focused ultrasound presentations were selected for the agenda, and they covered topics such as the use of pulsed focused ultrasound to modulate an immune response in breast and melanoma tumor models; the use of focused ultrasound and microbubbles for cancer therapy; a new idea for prostate cancer treatment; and the development of novel tools for studying focused ultrasound for brain neuromodulation. Two teams developed simulation tools for transcranial research. The Foundation funded the Brigham and Women’s/Harvard Medical School neuromodulation study.
The oral and poster presentations included the following abstracts:
Development of Wearable Focused Ultrasound Transducer for the Stimulation of Rat Brain by Ryan Margolin, Phillip Croce, Kyungho Yoon, Seung-Schik Yoo, and Wonhye Lee at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Multi-resolution Acoustic Simulation of Transcranial Focused Ultrasound by Kyungho Yoon, Phillip Croce, Ryan Margolin, Wonhye Lee, and Seung-Schik Yoo at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Transcranial Focused Ultrasound Aberration Correction by Jad El Harake and Charles Caskey at Vanderbilt University, Nashville, TN
Immune Modulating Effects of Pulsed Focused Ultrasound in Murine Breast and Melanoma Tumor Models by Omer Aydin, Scott Burks, and Joseph Frank at National Institutes of Health, Bethesda, MD
Quantitative T1 Mapping of Breast Cancer Xenografts during HIFU Ablation by Sara Johnson, Jill Shea, Alana Welm, Harika Gundlapalli, Maihi Fujita, and Allison Payne at the University of Utah, Salt Lake City, UT
HIFU Synergistically Enhances Thermally Triggered Chemotherapy for Liver Cancer: Evidence from in vitro and in vivo Studies by Gray Halliburton, Hakm Murad, Monica Kala, Yueheng Zhang, Vijay John, and Damir Khismatullin at Tulane University, New Orleans, LA
Development of HIFU-sensitive Nanomedicine-Microbubbles Complex for Cancer Therapy by Hyounkoo Han, Hohyeon Lee, Dae-in Park, and Hyuncheol Kim at Sogang University, Seoul, South Korea
Ethanol and HIFU Revert Prostate Cancer Cells to a Healthy Phenotype via ROS Production and NF-κB Blockage by Emma Bortz, Heng Yu, Hakm Murad, and Damir Khismatullin at Tulane University, New Orleans, LA
HIFU is Synergistic with Anti-neoplastic Drugs that target ER Stress by Hakm Murad, Emma Bortz, Partha Chandra, Debasis Mondal, and Damir Khismatullin at Tulane University, New Orleans, LA
The 2018 BMES annual meeting is scheduled for October in Atlanta.